Intervention group:

PreclinicalSmall molecule

HHong Kong Baptist University

Intervention group: is one of 20 small molecule programs targeting Intraoperative. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IntraoperativeCompleted

Menopausal SyndromeCompleted

IntraoperativePreclinical

Completed

Menopausal SyndromePreclinical

Completed

Competition

Competitive Landscape

24 competitors in Intraoperative

#DrugCompanyPhaseTrials

Zofran

Novartis

Approved

1 2

IC-Green

PProvepharm SAS

Approved

8 3

Ketalar

AAultman Health Foundation

Approved

5 4

Anerem

AAcacia Pharma Ltd

Approved

2 5

Reglan

IIstituto Clinico Humanitas

Approved

1 6

Ciprofol

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

1 7

Marcaine

IInnocoll

Phase 2

1 8

MS Contin

HHikma Pharmaceuticals LLC

Phase 2

1 9

Vancocin

HHikma Pharmaceuticals LLC

Phase 2

1 10

Robinul

Jazz Pharmaceuticals

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Post-ApprovalRecruiting

Alveolar Bone Grafting

NCT04234971

Clinical

Trials by Indication[1]

Hemorrhage1 trial

Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic

Unknown status·YYariv yogev·Phase 3·NCT02362945·1,000 enrolled

Alveolar Bone Grafting1 trial

Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate

Recruiting·TThe University of Texas Health Science Center, Houston·Phase 4·NCT04234971·40 enrolled

Menopausal Syndrome1 trial

Comparison Study for Perimenopausal Syndrome With Chinese Herbal Medicine

Completed·HHong Kong Baptist University·N/A·NCT05266079·100 enrolled

Intraoperative1 trial

Does Intraoperative Application of Steroids Affect Early Outcomes in Patients Undergoing Endoscopic Lumbar Discectomy?

Completed·—·N/A·NCT07411326·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Intervention group:. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intervention group: compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intervention group:. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hong Kong Baptist University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHong Kong Baptist University

Intervention group:

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Hemorrhage1 trial

Alveolar Bone Grafting1 trial

Menopausal Syndrome1 trial

Intraoperative1 trial

References

Drug Info

Quick Facts

Related News